How Congenital Heart Disease Treatment Is Tailored: Medication, Catheter Repair or Surgery

The sonographer had gone quiet. Not alarmingly quiet, just the kind of pause that makes a parent stop breathing for a second. A few minutes later, a fetal cardiologist was drawing four squares on a scrap of paper to show where a wall between two heart chambers hadn’t fully formed. The couple left with a word they had never heard, a follow-up appointment, and one question that would not leave: what happens now?

Roughly one baby in every hundred is born with a heart defect, and about a quarter of those defects are serious enough to need treatment in the first year, according to CDC data. Yet the phrase congenital heart disease treatment options covers an enormous range, from a decade of routine checkups with no intervention at all to a staged series of operations planned before birth.

What follows is how care teams actually choose among medication, catheter repair and surgery, and why the same diagnosis can lead to very different plans.

Congenital heart disease treatment options: why there is no single best one

People searching for the best treatment for congenital heart disease are asking a reasonable question that has an unsatisfying answer: there isn’t one, because congenital heart disease isn’t one condition. It is a family of dozens of structural problems that were present at birth. A pinhole between the two lower chambers of the heart and a heart with only one working pumping chamber both carry the label, but they have almost nothing in common clinically.

A congenital heart defect is a problem with the structure of the heart that developed before birth. Some involve holes in the walls that separate chambers (septal defects). Some involve valves that are too narrow (stenosis) or leak (regurgitation). Others involve blood vessels that are pinched, connected to the wrong chamber or missing altogether. MedlinePlus groups them broadly into defects that let too much blood flow to the lungs, too little, or mix oxygen-rich and oxygen-poor blood.

Each of those patterns calls for something different. A narrowed valve may respond to a balloon passed through a vein. A hole with a firm rim can hold a closure device. A missing chamber cannot be patched and needs a series of operations that reroute blood flow. That is why the honest answer to the best-treatment question is always: the best treatment for this particular heart, judged by a team that has looked at it in detail.

The scale of the field has changed, too. CDC estimates that about 1.4 million adults and 1 million children in the US are living with a congenital heart defect, meaning adults now outnumber children. Treatment decisions therefore span newborns, teenagers and people in their sixties, often for the same underlying defect at different stages of life.

How the decision actually gets made, from diagnosis to plan

Behind every treatment recommendation sits a surprisingly concrete sequence of measurements. The first is usually an echocardiogram, an ultrasound of the heart that shows its structure and the direction and speed of blood flow in real time. That single test tells a cardiologist where the defect is, how large it is, and how hard the heart is working to compensate.

From there the questions become quantitative. Is the extra blood flow through a hole large enough to stretch a chamber over time? Is the pressure across a narrowed valve high enough to strain the muscle behind it? Is oxygen mixing between the two sides of the heart, which shows up as lower oxygen levels in the blood? Mayo Clinic lists the tools used to answer these: electrocardiogram, chest X-ray, oxygen saturation measurement, cardiac MRI or CT for detailed anatomy, and sometimes a diagnostic cardiac catheterization, in which a thin tube is threaded into the heart to measure pressures directly.

The findings go to a multidisciplinary conference. Congenital cardiologists, cardiac surgeons, interventional cardiologists who perform catheter procedures, anesthesiologists and, for children, neonatologists review the images together. NHS guidance describes treatment as decided by a specialist team rather than a single doctor, and this is why. A surgeon and an interventionalist looking at the same hole may reach different views on whether a device will seat safely; the conference is where that gets argued out.

Timing matters as much as method. Some defects are treated in the first days of life because a baby cannot survive without intervention. Others are deliberately left until a child is bigger, when procedures are technically easier and devices fit better. Still others are watched for years and may never need anything. The plan you are given is a snapshot of that reasoning, and it can legitimately change as the heart grows or the picture shifts.

When watchful waiting is the treatment

It can feel wrong to be told a child has a heart defect and then be sent home with nothing but a follow-up date. Yet for a large share of defects, monitoring is the treatment, and an evidence-based one.

Small ventricular septal defects, holes between the two lower pumping chambers, frequently close on their own during early childhood as heart muscle grows around them, a pattern noted by Mayo Clinic and the NHS. Small atrial septal defects, holes between the upper chambers, can do the same. Mild narrowing of the pulmonary valve, which controls flow to the lungs, often stays mild and causes no strain. A patent ductus arteriosus, a fetal blood vessel that normally seals after birth, sometimes closes late without help, particularly in full-term babies.

Waiting is not passivity. Each visit repeats the measurements that matter: chamber size, pressure differences, oxygen levels, growth and feeding in babies, exercise tolerance in older children. The care team is looking for a trend, not a single number. A hole that is shrinking on successive scans supports continued observation. A chamber that is slowly enlarging is a signal that the extra flow is doing work the heart shouldn’t be doing, and the conversation shifts toward closure.

There is a second reason to wait when it is safe: procedures are easier on larger bodies. Closure devices come in fixed sizes and need a rim of tissue to grip. Surgical repairs on a heart the size of a walnut are harder than on one the size of a fist. The National Heart, Lung, and Blood Institute notes that some repairs are deliberately delayed until a child is older for exactly this reason.

What waiting is not is a reason to skip appointments. A defect that seemed trivial at two can behave differently at twelve, and the only way to know is to keep measuring.

What medicines do in congenital heart disease, and what they can't

Medication rarely fixes a structural heart problem. A drug cannot close a hole or widen a valve. What medicines do is buy time, ease the workload on a struggling heart, or manage the consequences of a defect and its repair. Understanding that distinction saves a lot of confusion.

In newborns, one of the most striking uses is holding a fetal vessel open. Certain critical defects depend on the ductus arteriosus, the temporary vessel that connects the aorta and the pulmonary artery before birth, to keep blood reaching the body or lungs. A prostaglandin infusion can keep that vessel from sealing until a procedure can be done, a bridge described in Mayo Clinic’s treatment guidance. The opposite situation exists too: in some premature babies a ductus that stays open unhelpfully can be encouraged to close with anti-inflammatory medicines from the NSAID class, a decision made entirely by the neonatal team.

For hearts under strain, the drug classes are the same ones used in other forms of heart failure. Diuretics reduce fluid that has backed up into the lungs or body, easing breathing and feeding in infants. ACE inhibitors relax blood vessels so the heart pumps against less resistance. Beta blockers slow the heart rate and reduce its oxygen demand. Digoxin can strengthen contraction and steady rhythm. Anti-arrhythmic medicines address abnormal rhythms, which become more common in adults with repaired defects.

After certain procedures, blood thinners (anticoagulants or antiplatelet medicines) are used for a period to prevent clots forming on a new device, patch or artificial valve. NHS guidance also notes that some people are advised to take antibiotics before dental work to reduce the risk of endocarditis, an infection of the heart’s lining or valves.

Every one of these decisions, including how long a medicine continues, belongs to the prescribing clinician who knows the specific heart. Medicines in this field are tools that support a plan, not the plan itself.

Catheter procedure for heart defects: how repair through a vein works

The idea still sounds improbable: repairing a heart without opening the chest. Cardiac catheterization does exactly that. A catheter is a thin, flexible tube inserted into a blood vessel, usually in the groin, and guided to the heart using X-ray imaging and often ultrasound. Through it, an interventional cardiologist can deliver balloons, closure devices, stents and even replacement valves.

Three types of repair account for most catheter work in congenital heart disease. The first is balloon dilation. A deflated balloon is positioned across a narrowed valve or vessel and inflated for a few seconds, stretching the tissue open. This is a standard approach for pulmonary valve stenosis and can be used for some aortic valve narrowing and for coarctation, a pinched section of the aorta. A stent, a small metal mesh tube, is sometimes left behind to hold the vessel open.

The second is device closure. For an atrial septal defect or patent ductus arteriosus with suitable anatomy, a collapsed device is passed through the catheter, opened on either side of the hole like two small umbrellas, and left in place. Over months, the heart’s own lining grows over it. Some ventricular septal defects can be closed this way, though many still need surgery because of their position near the heart’s electrical wiring.

The third, and most recent, is transcatheter valve replacement, chiefly of the pulmonary valve in people whose earlier surgical repair has worn out. The National Heart, Lung, and Blood Institute describes these approaches as offering shorter recovery than open surgery for the defects they suit.

Suitability is the key word. A hole needs a firm rim for a device to grip. A vessel must be reachable and of workable size. Catheter treatment is not a lesser version of surgery; it is a different tool with its own set of defects it fits well, and a team chooses it when the anatomy allows.

Congenital heart disease surgery: what open-heart repair involves

Surgery remains the definitive route for defects that catheters cannot fix: large or awkwardly placed holes, valves too damaged to stretch, vessels connected to the wrong chambers, and combinations of problems that need reconstruction rather than adjustment.

Most congenital heart operations are performed through a sternotomy, an incision down the center of the breastbone that is later closed with wires. The heart is usually stopped and its work taken over by a cardiopulmonary bypass machine, which oxygenates the blood and pumps it around the body while the surgeon works inside a still, empty heart. In some operations on the great vessels, bypass is not needed.

The repairs themselves are more varied than most people expect. A septal defect may be stitched directly or covered with a patch made from the patient’s own tissue or a synthetic material. A valve may be reshaped, its leaflets thinned or its ring tightened, or replaced with a mechanical or tissue valve. A narrowed aorta can be cut out and the ends rejoined. In transposition of the great arteries, where the two main vessels leaving the heart are swapped, the arterial switch operation moves them back and reattaches the tiny coronary arteries, typically in the first weeks of life, according to Mayo Clinic.

Some centers combine approaches in hybrid procedures, with a surgeon and interventionalist working together in one session, placing a stent through a small chest incision rather than a full sternotomy. Heart transplant is reserved for the small number of hearts that cannot be repaired or have failed after repair.

Risks are real and are discussed openly before consent: bleeding, infection, rhythm disturbances, stroke, and the effects of bypass itself. They vary enormously with the complexity of the defect, the age of the patient and their general health, which is one more reason outcome figures for one operation say little about another.

Staged operations for complex defects: the single-ventricle pathway explained

The hardest conversations in congenital cardiology happen when a baby has only one functioning pumping chamber, as in hypoplastic left heart syndrome, where the left side of the heart is severely underdeveloped. There is no patch for a missing ventricle. What surgeons can do is re-plumb the circulation so that a single chamber does the work of two, and that takes several operations spread across early childhood.

The logic is easier than the names. Normally the right ventricle pumps blood to the lungs and the left pumps it to the body. If only one ventricle works, it is given the body to look after, and blood is routed to the lungs without a pump, flowing passively from the veins under its own pressure.

The first operation, usually within the first weeks of life, makes the single ventricle the systemic pump and creates a controlled source of blood flow to the lungs, often through a small tube (a shunt). The second, typically in infancy, connects the vein returning blood from the upper body directly to the lung arteries. The third, generally in early childhood, does the same for the lower body, completing what is known as the Fontan circulation, in which all venous blood reaches the lungs without passing through a ventricle. Mayo Clinic and the NHS both describe this as a palliative pathway, meaning it restructures the circulation rather than restoring normal anatomy.

Between stages, babies are closely monitored, often with home oxygen saturation checks and weight tracking, because the interval circulation is delicate. After the final stage, the Fontan circulation works but is not normal, and it needs lifelong specialist follow-up for liver, rhythm and exercise-related effects.

Families on this pathway usually find that the most useful thing the team can give them is a map: which stage comes next, roughly when, and what the goals of each are.

Comparing congenital heart disease treatment options: medication, catheter, surgery

Laid side by side, the three approaches are easier to understand as a set of trade-offs than as a ranking. None is universally better. Each suits particular defects and particular moments in a person’s life, and many people will experience more than one.

Approach	What it does	Typically suited to	Typical hospital time	Main limits
Monitoring	Repeated imaging to track size, pressures and growth	Small septal defects, mild valve narrowing, defects likely to close on their own	None; outpatient visits	Requires reliable follow-up; picture can change
Medication	Eases heart workload, manages fluid, rhythm or clotting; stabilizes newborns before a procedure	Heart strain, arrhythmias, bridging to repair, post-procedure protection	Varies; often outpatient	Does not correct structure
Catheter repair	Balloons, stents, closure devices or valves delivered through a blood vessel	Suitable ASD and PDA, pulmonary or aortic valve stenosis, coarctation, worn pulmonary valves	Often same day or overnight (Mayo Clinic, NHLBI)	Needs suitable anatomy; devices need a rim to grip
Open surgery	Direct repair, patching, reconstruction or valve replacement on bypass	Large or complex defects, transposition, single-ventricle pathway, failed prior repair	Several days to a week or more (Mayo Clinic)	Longer recovery; bypass-related risks

Two things the table cannot show. First, sequence: a child might have a balloon procedure at six months, a surgical repair at four and a catheter valve replacement at thirty. Second, judgment: for some defects, catheter and surgical approaches both work, and the team’s recommendation reflects the exact anatomy on the scan and the experience of the people in the room. When a team explains why they chose one over the other, that reasoning is worth writing down, because it will make future decisions clearer.

Who is usually offered which option, and who is asked to wait

The pattern across guidelines is consistent enough to sketch, provided you hold it loosely. Individual anatomy overrides every generalization below.

Newborns with critical defects are treated early because they must be. CDC describes critical congenital heart defects as those needing surgery or a catheter procedure within the first year, and many need it within days. A baby whose body circulation depends on a closing fetal vessel, or whose lungs are receiving no blood, cannot wait for growth. These infants are stabilized with medication and then move to catheter or surgical treatment as soon as the team judges it safest.

Children with moderate defects that are causing strain, poor growth or repeated chest infections are usually treated in early childhood, often at a size chosen to balance the risks of the procedure against the harm of continued extra work on the heart. Where anatomy suits it, a catheter approach is commonly preferred; where it does not, surgery is planned.

Children and adults with small, quiet defects are asked to wait, sometimes indefinitely. The trigger to act is a change on imaging or in symptoms, not the mere existence of the defect.

Adults are a distinct group. Some arrive with a defect first found in adulthood, often a hole between the upper chambers picked up after a stroke or during an unrelated scan. Others return decades after a childhood repair with a valve that has worn out, a conduit that has narrowed or a rhythm problem. Mayo Clinic notes that adults with congenital heart disease may need repeat procedures, and that catheter valve replacement has become an option for some who would once have needed a second open operation.

Pregnancy planning shifts the calculus too. Some defects are treated before a planned pregnancy because the heart’s workload rises substantially during gestation; that timing is individual and is agreed with a specialist team.

What the days and weeks after treatment usually look like

Recovery has a shape that depends mainly on whether the chest was opened. Knowing the shape ahead of time makes the early days less frightening.

After a catheter procedure, the immediate priority is the small puncture site in the groin. Lying flat for a few hours reduces bleeding; a bruise is common. Mayo Clinic and the National Heart, Lung, and Blood Institute describe many catheter procedures as allowing discharge the same day or after one night, with a return to school or light work within days and a short pause on vigorous activity while the vessel heals. If a device was placed, a period on blood-thinning medicine is usual, with the duration set by the interventional team, and a follow-up echocardiogram checks the device’s position.

After open-heart surgery, the first hours are spent in an intensive care unit with a breathing tube, drains and monitoring lines, most of which come out within a day or two as the heart settles. Pain from the sternotomy is managed actively; sitting up, walking short distances and breathing exercises start early because they reduce lung complications. Mayo Clinic describes hospital stays of several days to a week or more, longer for complex repairs and for babies who need time to feed and gain weight.

The breastbone takes about six weeks to knit, according to NHS guidance on heart surgery recovery, and during that window lifting, pushing and pulling are restricted; toddlers are lifted under the arms and bottom rather than by the hands. Fatigue is normal and often outlasts the wound. Appetite can be slow to return. Low mood in the weeks after surgery is common and worth mentioning to the team rather than enduring alone.

The first outpatient review typically falls within a few weeks and includes an echocardiogram. From there, visits stretch out to intervals the cardiologist sets, and the pattern of lifelong follow-up begins.

Adult congenital heart disease treatment: why care doesn't end at 18

A generation ago, a child who had a heart defect repaired was often told the problem was fixed and discharged from cardiology in adolescence. Many of those people are now in their forties and fifties, and the field has learned that repaired is not the same as resolved.

Patches and valves placed in childhood do not grow, and tissue valves and conduits wear over decades. Scar lines from surgery can become the source of abnormal heart rhythms years later. A heart that pumped against extra resistance for years before repair may carry lasting changes in its muscle. Adults whose defects were never found until adulthood face their own version of this, with hearts that adapted quietly for years.

The response has been the growth of adult congenital heart disease as its own specialty. Mayo Clinic describes care for adults with congenital heart disease as typically lifelong, with regular checkups, imaging and, where needed, repeat procedures. The NHS makes the same point about transition from children’s to adult services, recommending planned handover rather than an abrupt end to follow-up.

Treatment in adulthood draws on the same three tools. Medication manages rhythm, fluid and blood pressure. Catheter procedures have expanded what can be done without a second operation, particularly replacing worn pulmonary valves and closing holes found late. Surgery remains available for the rest, and reoperation on a previously opened chest is routine for experienced teams though technically more demanding.

Life planning becomes part of the medicine. Pregnancy, contraception, exercise, employment involving physical exertion, and dental care all intersect with the heart. Endocarditis, infection of the heart lining or valves, is a lifelong consideration for some, and the team advises on whether antibiotics before dental procedures are warranted. Anyone who had a defect repaired in childhood and has not seen a cardiologist in years is the person adult congenital services most want to hear from.

Congenital heart disease prognosis: what the evidence does and doesn't say

Questions about prognosis, including the frequent search for the prognosis of congenital heart failure, deserve a careful answer rather than a reassuring or a frightening one. The honest position is that outlook depends more on which defect and how it was treated than on the label congenital heart disease itself.

The broad direction is clear. Mayo Clinic and the NHS both note that advances in diagnosis and treatment mean most children with congenital heart disease now grow into adulthood, and CDC’s estimate that adults living with these defects outnumber children reflects that shift. What no single figure captures is the spread within that population. Someone whose small hole closed on its own has a fundamentally different outlook from someone living with a single-ventricle circulation, and quoting one number for both would mislead.

Congenital heart failure is not a formal diagnosis. What people usually mean is heart failure that develops because of a congenital defect, either before repair, when the heart is overworked, or years afterward, when a repaired heart’s muscle or rhythm begins to struggle. Heart failure in this context is managed with the same medication classes and monitoring used in other forms, alongside consideration of whether a structural problem, such as a worn valve, can be fixed to take the load off. Its course depends on cause and response, and a specialist team is the right source for individual expectations.

Where guidelines are confident is on what improves the long-term picture in general terms: staying in follow-up, treating rhythm problems promptly, protecting against endocarditis where advised, and managing ordinary cardiovascular risk factors such as blood pressure and smoking, which matter as much to a repaired heart as to any other. Asking your own cardiologist what your specific defect and repair typically look like over decades will yield a far more useful answer than any general statistic.

What people often get wrong about CHD treatment

Several beliefs circulate widely enough that correcting them is part of good care.

The first is that surgery fixes the heart permanently. Many repairs last a lifetime, but valves, patches and conduits are not immune to wear, and rhythm problems can appear decades later. This is why every major source, from the NHS to Mayo Clinic, describes follow-up as lifelong rather than ending when a child recovers.

The second is that a catheter procedure is a shortcut chosen to avoid a proper operation. It is a different technique with its own indications. When a team offers device closure of a hole, it is because the anatomy suits a device, not because surgery was too much trouble. Conversely, when surgery is recommended over a catheter approach, it is usually because the defect’s position or size makes a device unsafe.

The third is that a parent caused the defect. Most congenital heart defects have no identifiable cause. CDC notes that some are linked to genetic conditions, certain maternal illnesses or medicine exposures, but for the majority the cause is unknown, and guilt is misplaced.

The fourth is that children with heart defects must avoid exercise. For many, the opposite is true: activity is encouraged, with specific limits only for particular defects or in the weeks after a procedure. The care team sets those limits individually.

The fifth is that medication is a treatment failure. Medicines in congenital heart disease usually work alongside structural repair, protecting a device, steadying rhythm or easing workload while a body grows toward a planned procedure.

A sixth, quieter misconception is that a defect discovered in adulthood must have been missed through negligence. Some defects cause no symptoms for decades and are found incidentally; their late discovery says nothing about earlier care.

Questions to ask your care team

Consultations in congenital cardiology are dense, and the most useful questions are the ones that reveal the reasoning behind a plan rather than just its label. Consider bringing these, adapted to your situation.

• What exactly is the defect, and can you draw it for me alongside a normal heart?
• What is it doing to the heart right now, measured how, and what would change your recommendation?
• Why this approach rather than the alternatives? If we wait, what are we waiting for?
• If a catheter procedure is proposed, what makes the anatomy suitable, and what happens if the device or balloon does not work as planned during the procedure?
• If surgery is proposed, will the heart be stopped and placed on bypass, and how long is a typical stay for this specific operation?
• Is this expected to be a single procedure or the first of several? If several, what is the rough sequence?
• What medicines are likely afterward, for what purpose, and who decides when they stop?
• What activity restrictions apply, for how long, and what signs should prompt a call?
• How often will follow-up happen, and what will each visit check?
• For teenagers: how and when will care transfer to an adult congenital service?
• For adults: does this defect or repair affect pregnancy planning, dental care or the type of work I do?
• Who do I contact between appointments, and how quickly should I expect a response?

Writing down the answers, or asking permission to record the conversation, is common and welcomed by most teams. A second appointment to go over the plan once the first shock has passed is a reasonable request, not an imposition. Decisions about whether and when to treat rest with the treating team, but they are made better when the person or family they concern understands the reasoning well enough to ask the next question.

When to call your doctor

Most people living with a congenital heart defect, treated or monitored, go long stretches without any acute problem. The value of knowing red-flag signs is that when something does change, it is recognized quickly. The list below draws on NHS and Mayo Clinic guidance; the team looking after you or your child may add specifics for the particular defect.

Seek emergency care immediately for a blue or gray tint to the lips, tongue or skin that is new or worsening; severe difficulty breathing or breathing that is rapid and labored at rest; fainting or collapse; chest pain that is severe or accompanied by sweating, nausea or breathlessness; a very fast, irregular or pounding heartbeat that does not settle; or, in a baby, extreme lethargy, refusal to feed over several feeds, or grunting with each breath.

Contact the cardiology team or a doctor the same day for a fever after a recent procedure, or any fever in someone told they are at risk of endocarditis; redness, swelling, discharge or opening of a wound; new swelling of the legs, abdomen or around the eyes; a baby sweating heavily or tiring during feeds, or failing to gain weight; a child or adult who cannot keep up with activities they managed a week ago; dizziness on standing; or a persistent cough with frothy or pink sputum.

Do not stop or change any prescribed medicine on your own, even if you suspect it is causing a side effect; call the prescribing team and describe what you are seeing.

Keep the team’s direct contact details somewhere everyone in the household can find, and make sure schools, childcare and, for adults, close colleagues know that a heart condition exists and whom to call. A brief written summary of the defect and any repairs, carried in a wallet or on a phone, helps emergency staff who have never seen you before.

Frequently asked questions

What is the best treatment for congenital heart disease?

There is no single best treatment, because congenital heart disease covers dozens of different structural defects. The right approach depends on which defect is present, how large it is and how it is affecting blood flow and heart strain. Small defects are often monitored, some are closed or widened through a catheter, and larger or complex problems are repaired surgically. A specialist team weighs these options for each individual heart.

Can you live a normal life with CHD?

Many people with congenital heart disease lead full lives that include school, work, sport, relationships and, for many, pregnancy. What normal looks like varies with the defect: someone whose small hole closed on its own may have no restrictions, while someone with a complex repair may need activity guidance and closer monitoring. Lifelong follow-up with a cardiologist is the common thread, and specific limits are set individually by the care team.

What is the prognosis for congenital heart failure?

Congenital heart failure is not a formal diagnosis; the phrase usually means heart failure caused by a congenital defect, either before repair or years after one. Its course depends on the underlying defect, whether a structural cause such as a worn valve can be fixed, and how the heart responds to medication and rhythm management. Because the range is so wide, a specialist team’s assessment of the individual situation is more useful than any general figure.

How is congenital heart disease surgery different from a catheter procedure?

Surgery opens the chest, usually through the breastbone, and typically stops the heart on a bypass machine so the surgeon can patch holes, reconstruct valves or reroute vessels directly. A catheter procedure threads a thin tube through a blood vessel to deliver balloons, stents or closure devices without opening the chest. Catheter treatment suits defects with favorable anatomy and usually means a shorter stay; surgery handles what catheters cannot reach.

Do all heart defects need treatment?

No. Many small defects cause no strain and are simply monitored with periodic echocardiograms. Small ventricular and atrial septal defects frequently close on their own during childhood, and mild valve narrowing often stays mild. Treatment is prompted by evidence that the defect is doing harm, such as enlarging chambers, rising pressures, poor growth or symptoms, rather than by its existence alone. Regular follow-up is what makes safe waiting possible.

What does adult congenital heart disease treatment involve?

Adult care uses the same three tools as pediatric care: medication for rhythm, fluid and blood pressure; catheter procedures, including replacement of worn pulmonary valves and closure of holes found late; and surgery for problems that need direct repair or reoperation. Care also covers pregnancy planning, dental and endocarditis precautions and exercise guidance. Adults repaired as children who have not seen a cardiologist in years are encouraged to re-establish specialist follow-up.

How long does recovery take after congenital heart surgery?

Recovery varies with the operation and the person. Mayo Clinic describes hospital stays of several days to a week or more after open-heart surgery, longer for complex repairs. NHS guidance notes the breastbone takes about six weeks to heal, during which lifting and strenuous activity are restricted. Fatigue often outlasts the wound. Catheter procedures generally involve a much shorter stay and a return to normal activity within days.

Why do medicines matter if they can't fix the defect?

Medicines support the structural plan rather than replace it. In newborns, a prostaglandin infusion can keep a fetal vessel open until a procedure is possible. Diuretics, ACE inhibitors and beta blockers ease the workload on a strained heart. Anti-arrhythmic medicines manage rhythm problems, and blood thinners protect new devices or valves from clots. Which medicines are used, and for how long, is decided by the prescribing clinician.

Will a repaired heart defect come back?

The original defect does not reappear, but repairs can wear. Tissue valves and conduits placed in childhood do not grow and can narrow or leak over decades, patches occasionally develop small leaks, and surgical scar lines can become sources of abnormal rhythm years later. This is why every major guideline describes follow-up as lifelong. Many people need further procedures in adulthood, increasingly through catheter approaches rather than repeat open surgery.

Is a catheter procedure for a heart defect safe for babies?

Catheter procedures are performed on babies, including newborns, when anatomy suits them, and for some defects they are the standard first treatment. Risks include bleeding or injury at the vessel entry site, rhythm disturbances during the procedure, device movement and, rarely, the need to convert to surgery. The team weighs these against the risks of surgery and of waiting, and discusses them before consent. Suitability is judged on the individual scan.

References

• NHS – Congenital heart disease: Treatment
• CDC – About Congenital Heart Defects
• NIH National Heart, Lung, and Blood Institute – Congenital Heart Defects: Treatment
• MedlinePlus – Congenital Heart Defects

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.